1-20 of 56
Original Paper
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Coronary Artery Disease and Microvascular Ischemia in Patients with Cardiac Amyloidosis

Available to Purchase
Subject Area:
Hematology , Oncology
Osnat Itzhaki Ben Zadok, Iuliana Vaxman, Sara Hoss, Yeela Talmor-Barkan, Tali Steinmetz, Pia Raanani, Ran Kornowski, Ashraf Hamdan
Journal: Acta Haematologica
Acta Haematol 1–10.
https://doi.org/10.1159/000542510
Published Online: 25 November 2024
View articletitled, Coronary Artery Disease and Microvascular Ischemia in Patients with Cardiac Amyloidosis
Open the PDF for Coronary Artery Disease and Microvascular Ischemia in Patients with Cardiac Amyloidosis in another window
Journal Articles

Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria

Open Access
Subject Area:
Hematology , Oncology
Alexander D. Kulagin, Vadim V. Ptushkin, Elena A. Lukina, Igor L. Davydkin, Alexander V. Korobkin, Tatiana S. Konstantinova, Elena Yu. Komartseva, Natalia V. Minaeva, Tatiana A. Mitina, Olesya U. Klimova, Evgeniya G. Arshanskaya, Vitalii D. Latyshev, Oksana A. Markova, Eugene V. Zuev
Journal: Acta Haematologica
Acta Haematol 1–9.
https://doi.org/10.1159/000542294
Published Online: 25 November 2024
View articletitled, Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria
Open the PDF for Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria in another window
Journal Articles

Shorter Duration of Blinatumomab Administration to 14 Days Has Same Efficacy and Safety Profile in Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study

Available to Purchase
Subject Area:
Hematology , Oncology
Jinyu Kong, Wenjing Miao, Jialing Lu, Yin Liu, Xin Kong, Huiying Qiu, Baoquan Song
Journal: Acta Haematologica
Acta Haematol 1–6.
https://doi.org/10.1159/000542060
Published Online: 28 October 2024
View articletitled, Shorter Duration of Blinatumomab Administration to 14 Days Has Same Efficacy and Safety Profile in Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study
Open the PDF for Shorter Duration of Blinatumomab Administration to 14 Days Has Same Efficacy and Safety Profile in Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study in another window
Journal Articles

Efficacy of Haploidentical Allogeneic Hematopoietic Cell Transplantation following Two Courses of Venetoclax and Azacytidine Therapy in Patients over 55 Years Old with Acute Myelogenous Leukemia

Available to Purchase
Subject Area:
Hematology , Oncology
Junjie Cao, Xianxu Zhuang, Danjie Luo, Renzhi Pei, Ying Lu, Dong Chen, Shuangyue Li, Xiaohong Du, Xuhui Liu
Journal: Acta Haematologica
Acta Haematol 1–10.
https://doi.org/10.1159/000542034
Published Online: 25 October 2024
View articletitled, Efficacy of Haploidentical Allogeneic Hematopoietic Cell Transplantation following Two Courses of Venetoclax and Azacytidine Therapy in Patients over 55 Years Old with Acute Myelogenous Leukemia
Open the PDF for Efficacy of Haploidentical Allogeneic Hematopoietic Cell Transplantation following Two Courses of Venetoclax and Azacytidine Therapy in Patients over 55 Years Old with Acute Myelogenous Leukemia in another window
Journal Articles

Real-World Use of Ruxolitinib in Patients with Myelofibrosis and Anemia or Thrombocytopenia at Diagnosis

Open Access
Subject Area:
Hematology , Oncology
Jingbo Yu, Emily Bland, Tammy Schuler, Thomas Cordaro, Evan Braunstein
Journal: Acta Haematologica
Acta Haematol 1–11.
https://doi.org/10.1159/000541549
Published Online: 21 October 2024
View articletitled, Real-World Use of Ruxolitinib in Patients with Myelofibrosis and Anemia or Thrombocytopenia at Diagnosis
Open the PDF for Real-World Use of Ruxolitinib in Patients with Myelofibrosis and Anemia or Thrombocytopenia at Diagnosis in another window
Journal Articles

Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature

Open Access
Subject Area:
Hematology , Oncology
Eyal Lebel, Vladimir Vainstein, Paolo Milani, Giovanni Palladini, Tamir Shragai, Noa Lavi, Hila Magen, Miri Assayag, Irit Avivi, Moshe E. Gatt
Journal: Acta Haematologica
Acta Haematol 1–8.
https://doi.org/10.1159/000541594
Published Online: 02 October 2024
View articletitled, Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature
Open the PDF for Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature in another window
Journal Articles

Prognostic Value of the Pretransplant Fibrosis-4 Index on Non-Relapse and Overall Mortality following Unrelated Single-Unit Cord Blood Transplantation in Adults

Open Access
Subject Area:
Hematology , Oncology
Takaaki Konuma, Maki Monna-Oiwa, Seiko Kato, Masamichi Isobe, Satoshi Takahashi, Yasuhito Nannya
Journal: Acta Haematologica
Acta Haematol (2025) 148 (3): 258–268.
https://doi.org/10.1159/000541157
Published Online: 28 August 2024
View articletitled, Prognostic Value of the Pretransplant Fibrosis-4 Index on Non-Relapse and Overall Mortality following Unrelated Single-Unit Cord Blood Transplantation in Adults
Open the PDF for Prognostic Value of the Pretransplant Fibrosis-4 Index on Non-Relapse and Overall Mortality following Unrelated Single-Unit Cord Blood Transplantation in Adults in another window
Journal Articles

Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall Survival

Available to Purchase
Subject Area:
Hematology , Oncology
Ni Bai, Wasithep Limvorapitak, Robert Henderson, Yasser Abou Mourad, Shanee Chung, Donna Forrest, Kevin Hay, Florian Kuchenbauer, Stephen Nantel, Sujaatha Narayanan, Thomas Nevill, Maryse Power, Judith Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan Stubbins, Heather Sutherland, Cynthia Toze, Jennifer White
Journal: Acta Haematologica
Acta Haematol (2025) 148 (3): 269–279.
https://doi.org/10.1159/000541071
Published Online: 28 August 2024
View articletitled, Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall Survival
Open the PDF for Real-World Impact of Routine Addition of Antithymocyte Globulin to Standard GVHD Prophylaxis in Myeloablative Unrelated Donor Transplants: Important Gains in Graft-versus-Host Disease Prevention though No Difference in Overall Survival in another window
Journal Articles

The Latin-American Experience in POEMS Syndrome: A Study of the GELAMM (Grupo de Estudio Latinoamericano de Mieloma Múltiple)

Available to Purchase
Subject Area:
Hematology , Oncology
Moisés Manuel Gallardo-Pérez, Paola Negrete-Rodríguez, Morie A. Gertz, Camila Peña, Eloisa Riva, Virginia Gilli, Gloritza Rodríguez, César Samánez, Joaquín Ferreira, Sergio Portiño, Jacqueline Montaña, Pilar León, Yaima Gutiérrez, Caroline Del-Castanhel, Cristian Seehaus, Maria Eugenia Funes, Rodrigo Meneces-Bustillo, Patricio Duarte, Claudia Shanley, Giannini Elvira, Paola Ochoa, Hernán López-Vidal, Humberto Martinez-Cordero, Jule Vasquez, Alana von-Glasenapp, Javiera Donoso, Jose Luis Viñuela, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles
Journal: Acta Haematologica
Acta Haematol (2025) 148 (3): 249–257.
https://doi.org/10.1159/000540890
Published Online: 10 August 2024
View articletitled, The Latin-American Experience in POEMS Syndrome: A Study of the GELAMM (Grupo de Estudio Latinoamericano de Mieloma Múltiple)
Open the PDF for The Latin-American Experience in POEMS Syndrome: A Study of the GELAMM (Grupo de Estudio Latinoamericano de Mieloma Múltiple) in another window
Journal Articles

Prognostic Factors for Chronic Thrombocytopenia in Systemic Lupus Erythematosus with Immune Thrombocytopenia

Available to Purchase
Subject Area:
Hematology , Oncology
Soo Min Ahn, Eun-Ji Choi, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo, Seokchan Hong
Journal: Acta Haematologica
Acta Haematol (2025) 148 (3): 280–288.
https://doi.org/10.1159/000540192
Published Online: 29 July 2024
View articletitled, Prognostic Factors for Chronic Thrombocytopenia in Systemic Lupus Erythematosus with Immune Thrombocytopenia
Open the PDF for Prognostic Factors for Chronic Thrombocytopenia in Systemic Lupus Erythematosus with Immune Thrombocytopenia in another window
Journal Articles

Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience and Literature Review

Available to Purchase
Subject Area:
Hematology , Oncology
Hunter D. Niehus, Jean Sabile, Richard T. Maziarz, Gabrielle Meyers, Rachel Cook, Arpita P. Gandhi, Jennifer N. Saultz, Shauna Rakshe, Andy Kaempf, Theodore Braun, Yazan Migdady
Journal: Acta Haematologica
Acta Haematol (2025) 148 (2): 198–207.
https://doi.org/10.1159/000539880
Published Online: 26 June 2024
View articletitled, Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience and Literature Review
Open the PDF for Enhanced Survival of Chronic Myelomonocytic Leukemia-Dysplastic over Proliferative Subtype after Allogeneic Hematopoietic Cell Transplant: A Tertiary Center Experience and Literature Review in another window
Journal Articles

Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies

Open Access
Subject Area:
Hematology , Oncology
Lindsey E. Roeker, Catherine C. Coombs, Nirav N. Shah, Wojciech Jurczak, Jennifer A. Woyach, Chan Y. Cheah, Krish Patel, Kami Maddocks, Yucai Wang, Pier Luigi Zinzani, Talha Munir, Youngil Koh, Meghan C. Thompson, Catherine E. Muehlenbein, Chunxiao Wang, Richard Sizelove, Sarang Abhyankar, Safarulla Hasanabba, Donald E. Tsai, Toby A. Eyre, Michael Wang
Journal: Acta Haematologica
Acta Haematol (2025) 148 (2): 180–197.
https://doi.org/10.1159/000539587
Published Online: 05 June 2024
View articletitled, Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies
Open the PDF for Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies in another window
Journal Articles

TES and SLC40A1 as Potential Biomarkers for Predicting Survival in T-Cell Acute Lymphoblastic Leukemia

Available to Purchase
Subject Area:
Hematology , Oncology
Xiangyou Zeng, Kaifan Liu, Ruohao Xu, Lenghe Zhang, Peilong Lai, Xin Du, Jianyu Weng
Journal: Acta Haematologica
Acta Haematol (2025) 148 (2): 163–179.
https://doi.org/10.1159/000539435
Published Online: 28 May 2024
View articletitled, TES and SLC40A1 as Potential Biomarkers for Predicting Survival in T-Cell Acute Lymphoblastic Leukemia
Open the PDF for TES and SLC40A1 as Potential Biomarkers for Predicting Survival in T-Cell Acute Lymphoblastic Leukemia in another window
Journal Articles

Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics

Available to Purchase
Subject Area:
Hematology , Oncology
Maria Dampmann, Sarah Flossdorf, Julius Keyl, Hans Christian Reinhardt, Christine Hanoun
Journal: Acta Haematologica
Acta Haematol (2025) 148 (1): 77–84.
https://doi.org/10.1159/000539223
Published Online: 22 May 2024
View articletitled, Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics
Open the PDF for Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics in another window
Journal Articles

Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USA

Open Access
Subject Area:
Hematology , Oncology
Debora S. Bruno, Manoj Khanal, Xiaohong I. Li, Maricer P. Escalon, Katherine B. Winfree, Lisa M. Hess
Journal: Acta Haematologica
Acta Haematol (2025) 148 (2): 148–162.
https://doi.org/10.1159/000538836
Published Online: 20 May 2024
View articletitled, Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USA
Open the PDF for Racial and Ethnic Characteristics and Outcomes of Patients Diagnosed with CLL/SLL in the USA in another window
Journal Articles

HLA-DRB5 Overexpression Promotes Platelet Reduction in Immune Thrombocytopenia Mice Model by Facilitating MHC-II-Mediated Antigen Presentation

Available to Purchase
Subject Area:
Hematology , Oncology
Yujuan Ren, Qianqian Ying, Ying Chen, Cong Liao, Anrong Li, Qidong Ye
Journal: Acta Haematologica
Acta Haematol (2025) 148 (1): 68–76.
https://doi.org/10.1159/000538749
Published Online: 15 May 2024
View articletitled, HLA-DRB5 Overexpression Promotes Platelet Reduction in Immune Thrombocytopenia Mice Model by Facilitating MHC-II-Mediated Antigen Presentation
Open the PDF for HLA-DRB5 Overexpression Promotes Platelet Reduction in Immune Thrombocytopenia Mice Model by Facilitating MHC-II-Mediated Antigen Presentation in another window
Journal Articles

Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs

Available to Purchase
Subject Area:
Hematology , Oncology
Julie Barberio, Timothy L. Lash, Ajay K. Nooka, Ashley I. Naimi, Rachel E. Patzer, Christopher Kim
Journal: Acta Haematologica
Acta Haematol (2025) 148 (2): 135–147.
https://doi.org/10.1159/000539127
Published Online: 10 May 2024
View articletitled, Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs
Open the PDF for Real-World Risk of Severe Cytopenias in Multiple Myeloma Patients Sequentially Treated with Immunomodulatory Drugs in another window
Journal Articles

Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12–<18 Years at Enrolment into PROTECT VIII

Open Access
Subject Area:
Hematology , Oncology
Mark T. Reding, Mindy Simpson, Jonathan Ducore, Pål Andrè Holme, Monika Maas Enriquez, Maria Elisa Mancuso
Journal: Acta Haematologica
Acta Haematol (2025) 148 (1): 58–67.
https://doi.org/10.1159/000538702
Published Online: 23 April 2024
View articletitled, Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12–&lt;18 Years at Enrolment into PROTECT VIII
Open the PDF for Long-Term Efficacy and Safety of Damoctocog Alfa Pegol Prophylaxis in Patients with Haemophilia A Aged 12–<18 Years at Enrolment into PROTECT VIII in another window
Journal Articles

Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial

Open Access
Subject Area:
Hematology , Oncology
Hisakazu Nishimori, Hideyuki Nakazawa, Shinobu Tamura, Toshiki Uchida, Kensuke Usuki, Johan Szamosi, Régis Peffault de Latour, Alexander Röth, Jens Panse
Journal: Acta Haematologica
Acta Haematol (2025) 148 (1): 22–35.
https://doi.org/10.1159/000537696
Published Online: 17 April 2024
View articletitled, Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial
Open the PDF for Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial in another window
Journal Articles

Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria

Open Access
Subject Area:
Hematology , Oncology
Xianghong Jin, Xianyong Jiang, Hui Li, Kaini Shen, Shuangjiao Liu, Miao Chen, Chen Yang, Bing Han, Junling Zhuang
Journal: Acta Haematologica
Acta Haematol (2025) 148 (1): 48–57.
https://doi.org/10.1159/000538658
Published Online: 16 April 2024
View articletitled, Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria
Open the PDF for Prognostic Implications of Circulating Plasma Cell Percentage in Multiple Myeloma and Primary Plasma Cell Leukemia Defined by New Criteria in another window